Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis

NCT05759767 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT05759767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05759767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis
Lead sponsor
Mansoura University
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2021
Completion date
December 1, 2023
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

extracorporeal shock wave lithotripsy, pediatric disorder, stone, kidney, stone, urinary, tamsulosin